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Protein C activation by a-thrombin on the surface of endothelial cells depends on an essential membrane-
glycoprotein cofactor, thrombomodulin. In the present study we have monitored the activity of
thrombin-thrombomodulin complexes on human saphenous-vein endothelial cells (HSVEC) or on the
endothelial cell line EA.hy 926. Cell monolayers were exposed for 5 min to 8.5 nm human a-thrombin and
then washed to remove unbound thrombin. The cells were then incubated at 37 °C for 5-180 min. At the
end of the respective incubation periods, purified human protein C (120 nM) was added in order to assay the
activity of the thrombin-thrombomodulin complexes present on the cell surface. HSVEC pre-exposed to
thrombin retained their full capacity to promote protein C activation up to 90 min after free thrombin was
removed. This capacity then decreased slowly to reach 560 of control value after 180 min of incubation.
Original activity was 3.8 + 0.9 pmol of activated protein C formed/min per ml per 106 cells (mean +s.E.M.
n = 5). The capacity of protein C activation of EA.hy 926 cells remained constant for 120 min after free
thrombin was removed, then decreased to 760 of control after 180 min. Original activity was 2.0 + 0.4 pmol
of activated protein C formed/min per ml per 106 cells (mean + S.E.M., n = 3). Similar results were obtained
with cells fixed with 30 paraformaldehyde. However, during the 5-180 min incubation period, non-fixed
cells of both types were capable of significantly internalizing fluorescent acetylated low-density lipoprotein.
In the experimental protocol used here, an eventual inhibition of thrombin internalization by protein C can
be excluded, as protein C is only added at the end of the incubation period. We conclude that there is no
evidence of rapid internalization of thrombin-thrombomodulin complexes on HSVEC or the EA.hy 926 cell
line, as assessed by the ability of membrane-bound thrombin to activate protein C.
INTRODUCTION
Protein C is the vitamin K-dependent precursor of a
serine proteinase, activated protein C, which has potent
anticoagulant capacity. Thrombin is the only known
physiological activator of protein C, in the presence of
an essential endothelial-cell cofactor, thrombomodulin
(Esmon, 1987). Thrombomodulin is a glycoprotein with
an Mr of 75000, showing structural similarities to the
low-density-lipoprotein (LDL) receptor (Jackman et al.,
1986, 1987; Suzuki et al., 1987; Wen et al., 1987).
Endothelial cells would contain between 30000 and
50000 thrombomodulin molecules per cell, which repre-
sent about 50 60 of the total thrombin-binding sites
(Maruyama & Majerus, 1985). The binding of thrombin
to thrombomodulin has two anticoagulant functions:
the neutralization of thrombin's procoagulant activities
and the acceleration of the activation of protein C [for a
review, see Freyssinet & Cazenave (1988)].
The fate of thrombin after it has bound to thrombo-
modulin has not been precisely elucidated. The bound
thrombin is still susceptible to inhibition by plasma
antithrombin III and subsequent removal from the
circulation (Owen et al., 1986). A covalent adduct of
thrombin with endothelial cells is created by the inter-
action of the serine proteinase with a secreted inhibitor
or the proteinase nexin; the enzyme-inhibitor complex is
then taken up and degraded (Savion et al., 1981). Throm-
bin inactivated with di-isopropyl phosphofluoridate
(iPr2P-F) (iPr2P-thrombin) and labelled with 1251 binds
to the endothelium, can be displaced by an excess of
iPr2P-thrombin, but remains bound to high-affinity bind-
ing sites for periods of up to several hours without
being processed (Owen et al., 1986). On the other hand,
it was shown that, in the A549 cell line and partially
in human umbilical-vein endothelial cells, thrombin-
thrombomodulin complexes were internalized, followed
by intracellular degradation of thrombin and reappear-
ance of thrombomodulin on the cell surface after 30 min
(Maruyama & Majerus, 1985). If thrombomodulin is
emerging as the major binding site of thrombin on the
endothelial surface, its role in the eventual intracellular
processing of the enzyme remains to be fully elucidated.
The activity of thrombomodulin-bound thrombin
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Abbreviations used: iPr2P-F, di-isopropyl phosphofluoridate; PBS, phosphate-buffered saline (137 mM-NaCl/2.7 mM-KCI/0.9 mM-CaCl2/
0.5 mM-MgCl2/1.5 mM-KH2PO4/6.5 mM-Na2HPO4, pH 7.4; 0.295 osM); S-2238, H-D-phenylalanyl-L-pipecolylarginine p-nitroanilide dihydro-
chloride; S-2366, L-pyroglutamyl-L-prolyl-L-arginine p-nitroanilide hydrochloride; LDL, low-density lipoprotein; DiI-Ac-LDL, acetylated LDL
labelled with 1,1'-dioctadecyl-3,3,3',3'-tetramethylindocarbocyanine perchlorate; APC, activated protein C; a.t.u., antithrombin unit; HSVEC,
human saphenous-vein endothelial cell; Tyrode/albumin buffer and HAT are defined in the text; EGF, epidermal growth factor.
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should be a good estimate of the amount of thrombin
bound to the endothelial-cell receptor. The present study
was designed to monitor with time the ability of human
ct-thrombin bound to human saphenous-vein endothelial
cells (HSVECs) or the endothelial cell line EA.hy 926 to
activate human protein C.
MATERIALS AND METHODS
Materials
Materials were obtained from the following sources:
cell-culture media {M199, RPMI 1640, Hepes, L-glut-
amine, penicillin, streptomycin, and trypsin-EDTA solu-
tion [trypsin (0.5 g/l)/EDTA (0.2 g/l)/NaCl (0.85 g/l)]}
were from Gibco, Paisley, Renfrewshire, Scotland, U.K.;
fatty-acid-free human serum albumin from Sigma, St.
Louis, MO, U.S.A.; hirudin from Stago, Asnieres,
France; acetylated LDL labelled with 1,1'-dioctadecyl-
3,3,3',3'-tetramethylindocarbocyanine perchlorate (DiI-
Ac-LDL) from Biomedical Technologies, Cambridge,
MA, U.S.A.; S-2366 (L-pyroglutamyl-L-prolyl-L-
arginine- p-nitroanilide hydrochloride) and S-2238 (H-D-
phenylalanyl-L-pipecolylarginine p-nitroanilide dihydro-
chloride) from Kabi Vitrum, Stockholm, Sweden;
HAuCl4 (tetra-aurochloric acid) from Aldrich, Stras-
bourg, France. All other chemicals were obtained from
Merck, Darmstadt, Germany, and were of analytical
grade.
Purification of human plasma proteins
Human a-thrombin [3000 National Institutes of
Health (NIH) units/mg of protein] was obtained by
activating purified prothrombin with Taipan-snake
(Oxyranus scutellatus scutellatus) venom (Owen & Jackson,
1973; Freyssinet et al., 1986). Protein C was purified to
homogeneity (as judged by SDS/polyacrylamide-gel
electrophoresis) from human plasma cryosupernatant as
previously described (Freyssinet et al., 1985).
Cell culture
Human endothelial cells were obtained from fragments
of saphenous veins obtained during coronary-bypass
surgery. The veins were kept in Hank's balanced salt
solution with 1 % human serum albumin (Centre
Regional de Transfusion Sanguine, Strasbourg, France).
The vessels were opened with scissors, rinsed gently with
PBS and the endothelial-cell layer gently scraped off with
a scalpel blade. The blade was shaken in culture medium.
The cells were cultivated by previously described method
(Klein-Soyer et al., 1986) that is a modification of those
of Jaffe (1980) and Willems et al. (1982). The culture
medium was M199/RPMI 1640 (1: 1) containing
10 mM-Hepes, 2 mM-L-glutamine, antibiotics (100 units
of penicillin and 100,ug of streptomycin/ml) and 300
pooled human serum. The suspension of scraped cells
was homogenized with a silicone-treated Pasteur pipette
and seeded in Petri dishes (35 mm diam.; Corning, New
York, NY, U.S.A.) pretreated with a human plasma
fraction enriched in fibronectin (560) by cryoprecipita-
tion. The cells were passaged using trypsin-EDTA at a
split ratio of 1:4. Cells were used in these experiments at
the second or third passage. Protein C cofactor activity
was shown to be constant up to the eighth passage
(Cazenave et al., 1985). The human cells line EA.hy 926
was derived by fusing human umbilical-vein endothelial
cells with the permanent cell line A549 (Edgell et al.,
1983). It was grown on dishes precoated with a human
plasma fraction enriched in fibronectin. The medium was
RPMI/M 199 (1: 1), containing 10 mM-Hepes, 2 mM-L-
glutamine, antibiotics (100 units of penicillin or 100,ug of
streptomycin/ml), HAT (100/tM-hypoxanthine/0.4/tM
aminopterin/ 16 jaM-thymidine) and 100% human pooled
serum. The cells were passaged using trypsin-EDTA at a
split ratio of 1: 10.
Protein C cofactor activity
Cells grown to confluence in 35 mm-diameter Petri
dishes were washed three times with I ml of warm
(37 °C) PBS and twice with Tyrode/albumin buffer
(NaCl, 137 mM; KCI, 2.7 mM; NaHCO3, 12 mM; NaH2PO4,
0.4 mM; MgCl2, 1 mM; CaCl2, 2 mM; Hepes, 5 mM;
glucose, 1 g/l; human fatty-acid-free serum albumin,
0.35 %, w/v; pH 7.35; osmolarity 0.295 osM). When cell
fixation was required, 1 ml of 30 paraformaldehyde in
PBS was added after washing the monolayer with PBS
and left for 20 min at room temperature. The fixed cells
were washed three times with PBS and were then
processed similarly to the non-fixed cells.
A portion (1 ml) ofwarm (37 °C) Tyrode/albumin was
added and 30 jal of human a-thrombin (30 NIH units/
ml) or Tris/NaCI (50 mM-Tris/0. 1 M-NaCl, pH 7.5)
buffers were used as controls. The dishes were left for
5 min in the incubator [37 °C; CO2/air (1: 19); saturation
humidity]. The cells were then washed twice with cold
(4 °C) Tyrode/albumin, and reincubated at 37 °C in 1 ml
of Tyrode/albumin for 5-180 min. After 5, 10, 20, 40, 60,
90, 120 and 180 min, two dishes were removed from the
incubator, 10,I of protein C (12jM) was added, and
the dishes were incubated at 37 °C for 15 min. As
recommended by Salem et al. (1984), less-than-saturating
concentrations of protein C were used in order to
conserve material, and incubation times were adjusted so
that less than 200 of the protein C was activated. The
reaction was terminated by addition of 5 a.t.u. of hirudin
in 5,jl, and the concentration of APC formed was
determined by reference to a standard curve constructed
with known amounts of APC (Freyssinet et al., 1986). It
was verified that the presence of hirudin had no effect on
the amidolytic activity of activated protein C.
Internalization of fluorescent acetylated LDL
This experiment was performed as a control on the
same day and using the same cells as for the activation of
protein C. The cells, grown to confluence in 35 mm-
diameter Petri dishes, were washed three times with PBS
and twice with Tyrode/albumin buffer. They were then
incubated at 37 'C in 1 ml of Tyrode/albumin buffer
with 50,ul of acetylated LDL labelled with 1 ',l '-
dioctadecyl-3,3,3',3 '-tetramethylindocarbocyanine
(DiI-Ac-LDL) (200 mg/ml in 0.15 M-NaCl/0.05 M-Tris/
2 jaM-EDTA, pH 7.4) to reach a final DiI-Ac-LDL con-
centration of 10,ug/ml. Dishes were removed from the
incubator after 30 and 180 min, washed three times with
PBS and fixed in 30 paraformaldehyde. They were
examined with a Nikon Diaphot TMD inverted micro-
scope equipped with an epifluorescence attachment, using
the standard rhodamine excitation/emission filter com-
bination.
Preparation of thrombin-colloidal-gold probes
Colloidal gold particles, averaging 15 nm in diameter,
were prepared as described (Frens, 1973). Briefly, 165 jl
1989
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of HAuCl4 was added to 10 ml of boiling water and
stirred vigorously before the addition of 1 ml of freshly
prepared 1% sodium citrate. After 5 min at 100 °C the
solution became orange-red and was left to cool to room
temperature. Human a-thrombin was dialysed for 4 h
against 5 mM-sodium carbonate buffer, pH 7.5 at 4 'C.
The thrombin (1000 NIH units in S ml of 5 mM-
Na2CO3, pH 7.5) was added under stirring to 10 ml of
colloidal gold in 5 mM-Na2CO3, pH 9.8. This amount of
thrombin was determined by using the serial-dilution-
electrolyte-flocculation test (Horisberger, 1979). The
thrombin-colloidal-gold conjugate was then washed
three times by centrifugation at 50000 g for 15 min in
30 ml of 5 mM-Na2CO3/0.01 % Tween 20, pH 9.8.
Amidolytic activity, as assayed using the chromogenic
substrate S-2238, was 40 %0 of that of the thrombin
originally added. The ability of the thrombin-colloidal-
gold conjugate to cause washed human platelet aggrega-
tion or clotting of human citrated plasma was reduced to
120% of that of the thrombin originally added. These
values were comparable with those previously obtained
by Handley & Chien (1985) or Liu et al. (1985).
Labelling of endothelial cells with thrombin-colloidal-
gold probes
This experiment was performed on the same day and
by use of the same cells as those used for the activation
of protein C. The cells, grown to confluence in 35 mm-
diameter Petri dishes, were washed three times with PBS
and twice with Tyrode/albumin buffer. The amount of
thrombin-colloidal-gold possessing the plasma-clotting
activity of 2 NIH units of thrombin was incubated with
the cells for 90 s at 37 'C in 1 ml Tyrode/albumin buffer.
The dishes were then washed three times in PBS and
incubated in 1 ml of Tyrode/albumin at 37 'C for up to
180 min. They were then fixed by adding 1 ml of 2%
glutaraldehyde/0. 1 M sodium cacodylate/0. 1 M-sucrose,
pH 7.25, 0.510 osM, for 5 min at 37 'C, then 2 ml of pure
fixative for 1 h at 37 'C and overnight at 4 'C. The dishes
were washed in sodium cacodylate buffer, post-fixed in
1 % OSO4 in 0.1 M-sodium cacodylate, pH 7.4, for 1 h at
room temperature, dehydrated in ethanol and embedded
in Epon. Ultrathin sections, stained with lead citrate
and uranyl acetate, were examined using a Siemens
Elmiscope 10.
RESULTS
Activation of protein C on the surface of HSVECs
Monolayers of confluent fresh or fixed HSVECs were
exposed for 5 min to 8.5 nm human a-thrombin and then
washed. When protein C (120 nm, final concentration)
was added thereafter, its activation could only originate
from thrombin bound to thrombomodulin on the cell
surface. Fig. I shows that, when the cells were left to
incubate without protein C for as long as 90 min,
thrombin-thrombomodulin complexes remained virtu-
ally unchanged, as can be judged from the constant rate
of protein C activation on the surface of these cells.
After longer times of incubation, protein C activation
decreased, but 180 min after washing away the unbound
thrombin, 56 0 of the original protein C activation was
still observed (Fig. 1).
The amidolytic activity developed in the presence of
cells and of protein C without thrombin was 160 of the
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Fig. 1. Activation of protein C in the presence of HSVECs in
culture after exposure to thrombin
Confluent monolayers [(374+57) x I03 cells] of fresh (El)
or fixed (-) HSVECs were exposed to 8.5 nM human a-
thrombin for 5 min at 37 °C (stippled area). The mono-
layers were washed twice with cold Tyrode/albumin buffer
and re-incubated at 37 °C in 1 ml Tyrode/albumin. After
the various times indicated, human protein C (120 nm
final concn.) was added and cells were incubated for a
further 15 min at 37 'C. The reaction was terminated by
adding 5 a.t.u. of hirudin, and the activated protein C
generated was estimated. Activity is given as a percentage
of the protein C activation observed at 5 min after washing
away the thrombin. This '100% of control' corresponded
to 3.8 + 0.9 pmol of activated protein C formed/min per
ml per 106 cells. Control incubation in the absence of
protein C gave approx. 10% of the amidolytic activity
obtained in the presence of protein C. Points correspond











Fig. 2. Activation of protein C in the presence of EA.hy 926 cells
after exposure to thrombin
Confluent monolayers of fresh ([) or fixed (-) EA.hy 926
cells [(1114+ 183) x I03] were exposed to 8.5 nm human a-
thrombin exactly as described in the legend to Fig. 1. The
'I00 %' activity corresponds to 2.0 + 0.4 pmol of activated
protein C formed/min per ml per 1O6 cells. Control incuba-
tion performed in the absence of protein C gave approx.
15 00 of the amidolytic activity obtained in the presence of
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Fig. 3. Labelling of HSVECs and EA.hy 926 cells with DiI-Ac-LDL
Fluorescence micrographs of HSVECs (a) or EA.hy 926 cells (b) incubated for 180 min with 10 mg of DiI-Ac-LDL are shown.
Cells were revealed by using the standard rhodamine excitation/emission filter set. Cells that were fixed with 3 %o
paraformaldehyde before incubation with DiI-Ac-LDL showed only background fluorescence (result not shown). Magnification
x 360.
control experiments, where either protein C, thrombin
and protein C, or cells were absent from the system,
amidolytic activity was never higher than 15 0 of the
values observed with the full reagent combination.
Activation of protein C on the surface of
EA.hy 926-cell-line monolayers
The EA.hy 926 cell line has been established through
the fusion of human umbilical-vein endothelial cells
with the permanent cell line A 549 (Edgell et al., 1983).
It has been shown to possess various characteristics of
human endothelial cells, such as the synthesis of von
Willebrand factor, prostaglandin I2 and thrombomodulin
(Suggs et al., 1986). The presence of thrombin-
thrombomodulin complexes on the surface of these cells
was monitored after a short exposure to thrombin,
followed by washing, exactly as for HSVEC. The ability
of membrane bound thrombin to activate protein C
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remained constant at approx. 75-9000 of the original
value, even when the cells were incubated for as long as
180 min in the absence of protein C (Fig. 2).
The amidolytic activity detected in the presence of cells
and of protein C without thrombin was 1300 of the
activity observed in the presence of thrombin. In other
control experiments, where either protein C, thrombin
and protein C, or cells, were absent from the system,
amidolytic activity was never higher than 15 Qo of the
values observed with the full reagent combination.
Internalization of fluorescent acetylated LDL
Cells were incubated with Dil-Ac-LDL in the same
buffer (Tyrode/albumin) as used for the protein C
experiments. Even as soon as 30 min, both cell types were
capable of internalization of DiI-Ac-LDL and were
brightly stained after 180 min of incubation (Fig. 3).
When cells were fixed with 30 paraformaldehyde, no
intracellular staining was observed (results not shown).
Ultrastructural studies with thrombin-colloidal-gold
probes
Cells were incubated with the thrombin-colloidal-gold
probe under exactly the same experimental conditions as
those used for the study of a-thrombin interaction with
thrombomodulin. Membrane labelling was still observed
after 180 min, both as random labelling and in clusters
(results not shown). Intracellular labelling was limited to
260% of total label (as determined after counting the
beads in 122 different frames). Incubation of the cells
with the thrombin-colloidal-gold probe resulted in a
morphological change similar to that observed with
thrombin.
DISCUSSION
Maruyama & Majerus (1985) used a monoclonal
antibody (IgG-TM) to measure thrombomodulin on
cultured umbilical-vein endothelial cells and the cell line
A549. Using this antibody, they were able to show that
exposure of these cells to thrombin decreased thrombo-
modulin on the cell surface. Radioactive thrombin was
shown to be internalized and degraded. In experiments
similar to those reported here, 20 min after excess
thrombin was washed off, A549 cells lost their capacity
to activate protein C. These data were interpreted as
evidence that the thrombin-thrombomodulin complex
was cleared from the cell surface through internaliza-
tion of thrombomodulin with a half-time (t@) of less
than 15 min. In our study, the stability of the capacity to
activate protein C on the surface of HSVEC or EA.hy
926 cells over a 180 min period does not suggest that the
thrombin-thrombomodulin complexes are internalized.
The characteristics of protein C activation by thrombin
bound to the surface of paraformaldehyde-fixed cells
were similar to those observed for non-fixed cells (Figs.
I and 2), although, as previously demonstrated (Cazenave
et al., 1985), fixation leads to a 10-25 00 decrease in the
ability of cells to activate protein C. It was thus necessary
to check that the non-fixed cells used in our experiments
were still capable of endocytosis. Acetylated low-density
lipoproteins (Ac-LDL) are taken up by endothelial cells
by a receptor-mediated mechanism at an accelerated rate
compared with other cell types (Voyta et al., 1984).
Fluorescent-labelled Ac-LDL (Dil-Ac-LDL) was taken
up by both HSVECs and EA.hy 926 cells (Fig. 3). This
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uptake was already noticeable after 30 min of incubation
with the cells, and led to strong intracellular fluorescence
after 180 min. Fixed cells showed no intracellular label-
ling (results not shown). Thus, in the incubation con-
ditions for the functional activation of protein C used
here, receptor-mediated endocytosis of acetylated LDL
was still possible.
Handley & Chien (1985) have shown that, after 2 h of
incubation of thrombin-colloidal-gold probes with por-
cine aortic endothelial cells, internalization in coated
vesicles and lysosomes was limited to 25% of cell-
associated gold probes. We have obtained similar results
here using HSVEC. Although it is difficult to quantify
exactly the amount of internalized probe, there was
definitely not endocytosis of as much as 50-600% of
bound thrombin. Such a high degree of internalization
should have been observed if thrombin bound to
thrombomodulin (which should represent 50-60 0 of
total thrombin-binding sites) was internalized within
30 min (Maruyama & Majerus, 1985).
In previous reports a linear rate of protein C activation
was observed for at least 1 h on the surface of human
umbilical-vein endothelial cells (Esmon & Owen, 1981;
Owen & Esmon, 1981). In these experiments, protein C
was present during the whole incubation period.
Maruyama & Majerus (1987) have demonstrated that
protein C can inhibit the endocytosis of thrombin-
thrombomodulin complexes. However, the protocol used
in our study excludes this possibility, as cells were
incubated with bound thrombin for various times in the
absence of protein C. Protein C was added at the end of
the incubation period only, in order to reveal the amount
of thrombin-thrombomodulin complexes remaining on
the cell surface, and could thus not interfere with the
eventual endocytotic process.
The amino acid sequence of thrombomodulin shows a
striking similarity to that of the LDL receptor (Jackman
et al., 1986, 1987; Suzuki et al., 1987; Wen et al., 1987).
The epidermal-growth-factor (EGF)-like domain in the
LDL receptor would be involved in the acid--dependent
conformational changes necessary for the recycling of
the receptor in endosomes (Davis et al., 1987a). A critical
tyrosine residue at position 807 in the cytoplasmic tail
of the LDL receptor is essential for the clustering in
coated pits and subsequent internalization of the receptor
(Davis et al., 1987b). Both the EGF-like domain and the
cytoplasmic domain of thrombomodulin show simi-
larities to those of the LDL receptor. This has been put
forward to support the finding that thrombomodulin
could remove thrombin bound at the cell surface through
receptor-mediated endocytosis. However, the primary
binding site of thrombin on thrombomodulin has been
localized in the fifth and sixth EGF-like structures
(Kurosawa et al., 1988), whereas in the LDL receptor
LDL binds to the N-terminal domain before it is
internalized (Brown & Goldstein, 1986). If the interaction
of thrombin with thrombomodulin involves different
acceptor domains from the binding of LDL to its
receptor, this could suggest that postbinding fate of both
ligands would be also different, despite the common
structures of their receptor molecules. Results reported
here show that, in cells still capable of endocytosis of
LDL, thrombin-thrombomodulin complexes remain
functionally unchanged on the surface. It is very well
possible that the internalization ofradiolabelled thrombin
or of thrombin-colloidal-gold probes could be mediated
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through the attachment of the proteinase to a membrane
component other than thrombomodulin. This possibility
is further supported by the finding that IgG-TM, the
monoclonal antibody used to label thrombomodulin in
studies reported by Maruyama & Majerus (1985, 1987),
could also recognize two additional proteins, distinct
from thrombomodulin, which were expressed in a
human endothelial-cell cDNA library (Wen et al.,
1987).
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